Ignite Creation Date:
2024-05-06 @ 7:14 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02499835
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2015-07-14
Brief Title:
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Organization Data
Organization:
University of Wisconsin Madison
Class:
OTHER
Study ID:
UW15014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Wisconsin Madison
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Madison Vaccines Inc | UNKNOWN |
| Prostate Cancer Foundation | OTHER |